Bebo Health (XPAR:MLBBO) Stock Based Compensation: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLBBO Bebo Health SA XPAR:MLBBO
47 GF Score
Price €0.18
GF Value €0.03
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bebo Health Stock Based Compensation?

Bebo Health XPAR:MLBBO 47 Stock Based Compensation is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Bebo Health's Stock Based Compensation for the six months ended in Dec. 2025 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Bebo Health Stock Based Compensation Related Terms

Bebo Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Bebo Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bebo Health Stock Based Compensation Chart

Bebo Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bebo Health Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPAR:MLBBO
47GF Score
Bebo Health SA XPAR:MLBBO
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bebo Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Bebo Health (XPAR:MLBBO) has a Stock Based Compensation of €0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Bebo Health and its competitors.
Is Bebo Health's Stock Based Compensation too high?
Bebo Health's current Stock Based Compensation is €0.00 Mil. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Stock Based Compensation compare to CASY and WSM?
Bebo Health's Stock Based Compensation of €0.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Retail - Cyclical company?
A good Stock Based Compensation depends on the Retail - Cyclical industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Bebo Health and its competitors. Bebo Health's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current Stock Based Compensation is €0.00 Mil. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Stock Based Compensation is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?

Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued. The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03. GuruFocus considers Bebo Health to be Significantly Overvalued.

Key valuation signals for XPAR:MLBBO:

  • Stock Based Compensation: €0.00 Mil
  • GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bebo Health Business Description

Address 1 Rue de la Cite, Geneve, CHE, 1204
Bebo Health SA is a multilingual e-commerce portal specializing in products dedicated to health, sport and wellness.
47GF Score

Get the complete analysis for XPAR:MLBBO

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price
€0.03
GF Value